262855-60-7

Upstream product

• 96813-44-4 2-(p-nitrobenzyl)-3-monooxo-1,4,7-triazaheptane 
• 17193-40-7 (S)-4-nitrophenylalanine methyl ester hydrochloride 
• 96813-36-4 2-amino-3-(4-nitrophenyl)propyl (2'-aminoethyl)amine 
• 5292-43-3 bromoacetic acid tert-butyl ester 
• 388060-55-7 tert-butyl 2-{[2-(tert-butoxy)-2-oxoethyl]({1-hydroxy-3-[4-nitrophenyl]propan-2-yl})amino}acetate 

Downstream Products

• 121806-83-5 2-({2-[bis(carboxymethyl)amino]-3-(4-isothiocyanatophenyl)propyl}({2-[bis(carboxy methyl)amino]ethyl})amino)acetic acid 
• 128817-52-7 2-{[3-(4-aminophenyl)-2-[bis(carboxymethyl)amino]propyl] ({2-[bis(carboxymethyl)amino]ethyl})amino}acetic acid 

Relevant academic research and scientific papers

Nanofibers and morphology shifting micelles

The invention discloses novel morphology shifting micelles and amphiphilic coated metal nanofibers. Methods of using and making the same are also disclosed.

SYNTHESIS OF THERAPEUTIC AND DIAGNOSTIC DRUGS CENTERED ON REGIOSELECTIVE AND STEREOSELECTIVE RING OPENING OF AZIRIDINIUM IONS

Stereoselective and regioselective synthesis of compounds via nucleophilic ring opening reactions of aziridinium ions for use in stereoselective and regioselective synthesis of therapeutic and diagnostic compounds.